Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Takeda
This study is a retrospective, non-interventional and, post-authorization observational study of other designs (PAS-OD).
This multicenter trial will be conducted in Spain. Retrospective review of medical records and initial tumor biopsies of participants diagnosed with PTCL in the period of 6 years between 01/01/2008 and 31/12/2013 will be performed. Initial tumor biopsies and histological preparations, filed and previously anonymized, will be sent to the central laboratory for assessment.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants diagnosed with PTCL in the six years between 01/01/2008 and 31/12/2013.
Availability of initial tumor biopsy diagnosis in paraffin block (node or core biopsy of 16-18mm).
PTCL subtypes permitted by WHO 2008 classification of lymphoid neoplasms:
* Natural killer/ T-lymphocytes (NK /T-cell) lymphoma extranodal nasal type
* Enteropathic T-cell lymphoma
* Hepatosplenic T-cell lymphoma
* Peripheral T-cell lymphoma, not otherwise specified
* Angioimmunoblastic T-cell lymphoma
* Anaplastic large cell lymphoma, Anaplastic lymphoma kinase positive (ALK)+
* Anaplastic large cell lymphoma, ALK-
You may not be if
Participants with an unavailable history (lost, empty or not recoverable).